SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-17-000673
Filing Date
2017-02-09
Accepted
2017-02-09 17:01:26
Documents
1
Period of Report
2017-02-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT moll-form4_020717.html 4  
1 OWNERSHIP DOCUMENT moll-form4_020717.xml 4 3971
  Complete submission text file 0001387131-17-000673.txt   5454
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11455 EL CAMINO REAL, SUITE 310 SAN DIEGO CA 92130
Business Address
Moll Thomas (Reporting) CIK: 0001530181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36242 | Film No.: 17588350